IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.453
EU - Europa 5.726
AS - Asia 5.549
SA - Sud America 649
Continente sconosciuto - Info sul continente non disponibili 284
AF - Africa 83
OC - Oceania 10
Totale 21.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.175
SG - Singapore 2.018
CN - Cina 1.613
UA - Ucraina 976
IT - Italia 896
IE - Irlanda 778
TR - Turchia 701
SE - Svezia 637
RU - Federazione Russa 621
GB - Regno Unito 606
BR - Brasile 522
VN - Vietnam 455
FR - Francia 451
IN - India 421
DE - Germania 348
FI - Finlandia 207
CA - Canada 120
BD - Bangladesh 74
PL - Polonia 61
HK - Hong Kong 48
MX - Messico 42
AR - Argentina 37
IQ - Iraq 32
EC - Ecuador 31
KR - Corea 27
ID - Indonesia 23
ES - Italia 22
ZA - Sudafrica 22
CO - Colombia 19
IL - Israele 19
JP - Giappone 19
BE - Belgio 17
EU - Europa 17
NL - Olanda 17
NI - Nicaragua 15
RO - Romania 15
SC - Seychelles 15
GT - Guatemala 14
CZ - Repubblica Ceca 13
HN - Honduras 13
PK - Pakistan 13
JM - Giamaica 12
MA - Marocco 12
PY - Paraguay 12
SV - El Salvador 12
CR - Costa Rica 11
TT - Trinidad e Tobago 11
AT - Austria 10
AU - Australia 10
GR - Grecia 10
LT - Lituania 10
PH - Filippine 10
PR - Porto Rico 10
UZ - Uzbekistan 10
CL - Cile 9
CW - ???statistics.table.value.countryCode.CW??? 9
DZ - Algeria 8
KE - Kenya 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
GP - Guadalupe 7
JO - Giordania 7
PE - Perù 7
AL - Albania 5
AZ - Azerbaigian 5
IR - Iran 5
VE - Venezuela 5
CH - Svizzera 4
ET - Etiopia 4
MY - Malesia 4
PS - Palestinian Territory 4
PT - Portogallo 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
MD - Moldavia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
CU - Cuba 1
Totale 21.480
Salva come PNG Salva come JPEG
Città #
Singapore 1.338
Jacksonville 1.074
San Jose 860
Chandler 773
Dublin 763
Dearborn 454
Ashburn 434
Southend 420
Council Bluffs 407
Princeton 385
Dallas 363
Beijing 334
Izmir 332
Nanjing 326
Wilmington 257
Los Angeles 215
Cambridge 180
Ho Chi Minh City 156
Santa Clara 143
Tongling 135
Buffalo 133
New York 130
Woodbridge 117
Ann Arbor 113
The Dalles 110
Nanchang 104
Hanoi 95
Rome 83
Houston 70
Boardman 64
Moscow 63
Shenyang 62
Phoenix 57
Hebei 55
São Paulo 55
Altamura 54
Milan 54
Kunming 49
Hefei 48
Munich 48
Tianjin 46
Jiaxing 44
Hong Kong 38
Kraków 36
Chieti 35
Redondo Beach 35
Brooklyn 33
North Bergen 33
Hangzhou 32
Da Nang 29
Bologna 28
Columbus 28
Jinan 25
Silver Spring 25
Montreal 24
Norwalk 24
Toronto 24
London 23
Atlanta 22
Grevenbroich 22
Guangzhou 22
Washington 22
Boston 21
Chicago 21
Denver 20
Dong Ket 20
Orange 20
Changsha 19
Guayaquil 19
Seoul 19
Warsaw 19
Frankfurt am Main 18
Haiphong 18
Helsinki 18
Orem 18
Tokyo 18
Brasília 16
Brussels 16
Rio de Janeiro 16
San Francisco 16
Stockholm 16
Belo Horizonte 15
Düsseldorf 15
Pescara 15
Augusta 14
Chennai 14
Johannesburg 14
Managua 14
Vinh 14
Charlotte 13
Philadelphia 13
Turku 13
Baghdad 12
Lanzhou 12
Seattle 12
Changchun 11
Guatemala City 11
Hải Dương 11
Mount Pleasant 11
San Mateo 11
Totale 12.156
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 419
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 405
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 199
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 192
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 188
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 187
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 186
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 184
Antibacterial effect of plant extracts against Helicobacter pylori 184
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 176
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 171
24-hour pancolonic motility using a portable electronic probe in healthy subjects 169
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 165
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 165
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 164
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 164
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 164
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 162
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 160
Cigarette smoke, ferritin, and lipid peroxidation 159
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 159
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 158
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 155
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 154
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 153
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 153
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 151
Trasmissione di Helicobacter pylori in un modello murino 151
Detection of Helicobacter pylori in saliva and esophagus 149
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 147
Heightened free radical activity in angina pectoris 146
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 145
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 145
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 144
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 144
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 143
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 142
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 142
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 141
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 140
[Physiopathological bases of the medical treatment of portal hypertension]. 139
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 139
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 138
Heparin: does it act as an antioxidant in vivo? 137
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 136
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 136
Prolonged anal sphincter manometry in normal human subjects 135
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 135
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 133
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 133
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 133
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 132
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 132
Detection of Helicobacter pylori in esophagus and saliva in humans 132
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 130
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 130
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 129
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 129
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 128
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 126
Masse all'ipocondrio dx e carcinoma della colecisti 126
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 126
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 125
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 125
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 124
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 124
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 123
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 123
LA MALDIGESTIONE 123
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 122
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 122
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 121
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 121
Registrazione delle 24 ore della motilità del piloro in soggetti normali 120
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 120
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 120
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 120
Esophageal and gastric motility in patients with gastroesophageal reflux disease 119
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 119
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 118
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 118
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 117
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 117
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 116
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 116
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 115
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 114
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 114
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 114
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 114
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 113
EFFICACY OF FOUR DIFFERENT MOXIFLOXACIN-BASED TRIPLE THERAPIES FOR FIRST-LINE H. PYLORI TREATMENT 113
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 112
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 112
EVALUATION OF INTRA PARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSIS BY FIBROSCAN IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPARISON WITH NORMAL CONTROLS 112
Influence of physical activity on gastric emptying of liquids in normal human subjects 111
Evidence for an oral-faecal transmission of Helicobacter pylori infection in an experimental murine model 110
Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. 110
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 110
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 109
Totale 14.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022546 0 0 0 0 75 9 10 64 55 6 89 238
2022/20232.200 198 230 121 267 183 511 149 160 256 29 52 44
2023/20241.008 76 52 64 29 33 308 250 40 3 40 17 96
2024/20252.617 189 401 302 38 65 66 47 161 334 110 277 627
2025/20265.626 463 275 667 695 465 363 811 436 559 426 377 89
2026/20271.832 219 345 239 781 248 0 0 0 0 0 0 0
Totale 21.754